You will eat less on tirzepatide. That part is the drug doing its job, and it is measurable.
The harder question is what should be in the food that remains. Nobody has run the trial that answers it directly.
What the label actually asks for
The prescribing information lists the drug as indicated in combination with a reduced-calorie diet and increased physical activity [1].
That is the whole dietary instruction. No food group, macronutrient target or meal pattern appears in it.
The trials behind the label ran lifestyle counseling alongside the injection. SURMOUNT-3 went further and put everyone through a 12-week intensive lifestyle program first [2].
Only people who had already lost at least 5% that way were randomized. Over the next 72 weeks the tirzepatide arm lost a further 18.4%, while the placebo arm regained 2.5%.
Put differently: 87.5% of the drug arm lost another 5% or more, against 16.5% on placebo. Diet alone had already been tried, and the drug still had that much left to give.
Why protein comes up first
Weight lost is not only fat. In the SURMOUNT-1 scan substudy of 160 people, weight fell 21.3%, fat mass 33.9% and lean mass 10.9% [3].
Roughly 75% of what was lost was fat and 25% was lean tissue. The placebo group split the same way, which is what happens in weight loss generally.
A 24-week observational cohort followed 28 adults starting semaglutide or tirzepatide with no structured nutrition support [4]. About a quarter of their weight loss was estimated skeletal muscle.
In that cohort, higher absolute protein intake was associated with keeping more of it (r=0.41, P=0.0498). The authors call the finding exploratory, and the sample was small.
A 2026 nutrition review proposes daily protein of at least 1.2 g per kilogram, up to 1.6 g per kilogram in appropriate adults without kidney disease [5]. It suggests roughly 0.3 to 0.4 g per kilogram at each meal.
Those are the review's proposed targets, not a tested prescription. What the loss is made of is covered in GLP-1 muscle loss.
Eating less means fewer nutrients, not better ones
The same cohort found something worth planning around. Diet quality did not improve by itself, and food cravings were unchanged overall [4].
Intake fell across multiple micronutrients as total energy intake dropped. Smaller portions of the same food are still smaller portions of the same food.
The 2026 review suggests a laboratory panel covering vitamin D, B12, iron studies, folate and zinc, with thiamine in higher-risk patients [5]. That is a conversation to have with a prescriber, not a self-service checklist.
Eating around the side effects
Most of what makes eating difficult on this drug is gastrointestinal, and the rates are on the label[1].
| Reaction | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Nausea | 8% | 25% | 29% | 28% |
| Diarrhea | 8% | 19% | 21% | 23% |
| Vomiting | 2% | 8% | 11% | 13% |
| Constipation | 5% | 17% | 14% | 11% |
Nausea and diarrhea rise with dose; constipation runs the other way and is worst at the lowest dose. Both patterns matter for what sits well.
The label also notes that the dose ladder itself exists to reduce gastrointestinal reactions [1]. Symptoms concentrate around each step up.
If diarrhea is the problem rather than nausea, the pattern and timing are covered in tirzepatide diarrhea.
How much less you will want
A controlled study compared tirzepatide 15 mg, semaglutide 1 mg and placebo on appetite and intake at 28 weeks[7].
Both drugs reduced appetite scores and energy intake against placebo. Neither beat the other on those measures, even though weight loss differed.
The practical reading is that hunger stops being the thing that sets your intake. What you choose in the smaller window starts to matter more than it did.
What to raise with a prescriber
Ask what protein target fits your weight and kidney function. The reviews propose a range, not a number for everyone.
Ask whether any laboratory monitoring is worth doing as intake falls. Ask what to do on the weeks you step up a dose.
And ask about resistance training, since the reviews pair it with protein rather than treating either alone[5].
The same question for the other GLP-1 is answered in what to eat on semaglutide. To compare prescribers by monthly cost, see the compounded tirzepatide rankings, and for the rest of this goal, the weight hub.